India  

SARS-CoV-2

Virus that causes COVID-19

SARS-CoV-2    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

SARS-CoV-2: Virus that causes COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARSā€‘CoVā€‘2) is a strain of coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. The virus previously had the provisional name 2019 novel coronavirus (2019-nCoV), and has also been called human coronavirus 2019. First identified in the city of Wuhan, Hubei, China, the World Health Organization designated the outbreak a public health emergency of international concern from January 30, 2020, to May 5, 2023. SARSā€‘CoVā€‘2 is a positive-sense single-stranded RNA virus that is contagious in humans.

0
shares
ShareTweetSavePostSend
 

You Might Like


Scientists in Bengaluru discover means to tackle Covid-19 variants

Scientists discovered a way to fight current and future variants of SARS-CoV2 by boosting the body's antiviral defenses. They focused on enhancing antimicrobial peptides (AMPs) and found that higher..
IndiaTimes - Published

All Covid strains given to Bharat Biotech for a universal jab: Centre

Indian Council of Medical Research (ICMR) has transferred all existing strains of variants of concern of SARS-CoV-2 - virus that causes Covid-19 - to Bharat Biotech Ltd for developing a universal Covid..
IndiaTimes - Published

Indian scientists uncover hidden reservoir of SARS-CoV-2 in body cells, paving way for improved Covid-19 diagnosis


IndiaTimes - Published

This flu season, H3N2 trumps swine flu, Covid

In the battleground of viruses, a clear dominator this monsoon has been the influenza A subtype H3N2 that has surpassed two recent pandemic viruses, H1N1 (swine flu) and SARS-CoV-2. Co-circulating with..
IndiaTimes - Published

Evidence of viral resistance to Covid-19 drug Paxlovid found

A new research provided evidence of viral resistance to Paxlovid among SARS-CoV-2 variants currently circulating globally, indicating that this stand-alone drug could soon become less effective in..
IndiaTimes - Published

Enhanced recombination is a shot in the arm for SARS-CoV-2: IISc study


IndiaTimes - Published

ā€˜India detected 300 Omicron sub-lineages, none settledā€™

Between December 24 and January 3, the health ministry sources said, 124 people arriving to India from abroad were found positive for Covid-19. The sources said 11 variants of SARS-CoV-2 were..
IndiaTimes - Published

Covid positivity at 0.1% in last 24 hours: Govt

The sources said 11 variants of SARS-CoV-2, the virus that causes Covid-19, were identified in Whole Genome Sequencing (WSG) carried out on the samples of 40 passengers who were found positive.
IndiaTimes - Published

India-made drug shows promise in treating Covid heart damage

A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has..
IndiaTimes - Published

Main Omicron subvariant now mutating further: Insacog

BA.2.75 has spawned what has been designated as BA.2.75.2, which recently drew the attention of experts tracking mutations in SARS-CoV-2. Yunlong Richard Cao, an immunologist at Peking University,..
IndiaTimes - Published

BA.2.38 causing just mild illness: Study

Omicron sub-variant BA.2's offspring, BA.2.38, may be causing a spike in Maharashtra and other parts of India, but the illness it is causing is self-limiting and almost comparable with common cold-like..
IndiaTimes - Published

Anocovax: India's first Covid vaccine for animals launched

The immunity induced by Anocovax neutralises both Delta and Omicron variants of SARS-CoV-2, the Indian Council of Agricultural Research (ICAR) said.
DNA - Published

Are 3 doses of Covid-19 vaccine better than 2? Study says THIS

During study period, 197,535 (6.3 per cent) patients were infected with SARS-CoV-2, and of those, 15,786 (8 per cent) were admitted to the hospital.
DNA - Published

Omicron now dominant variant of SARS-CoV-2 in country: Government


IndiaTimes - Published

PM Modi to hold meeting today in wake of Omicron threat

With Omicron cases growing rapidly in the country, PM Narendra Modi has called for a high level meeting on Thursday to review Covid-19 situation.A total of 213 cases infected with Omicron variant of..
IndiaTimes - Published

Bharat Biotech seeks DCGI nod for phase-3 study of intra-nasal Covid vaccine as booster dose

"Bharat Biotech has put in an application seeking permission to conduct a study titled 'A Phase 3 Study to Evaluate the Safety and Immunogenicity of BBV154 and BBV152 as third dose (booster) to..
IndiaTimes - Published

Covid-19: FAQs on SARS-CoV-2 variant Omicron


IndiaTimes - Published

Omicron variant does not escape RT-PCR and RAT, Centre tells states as it asks them to ramp up testing

Underlining that the Omicron variant of SARS-CoV-2 does not escape RT-PCR and RAT tests, the Centre advised states and UTs on Tuesday to ramp up testing for early identification of any cases, undertake..
IndiaTimes - Published

Expert panel mulls nod to ā€˜additional doseā€™ of Covid vaccine to elderly

Amid mounting fear over the new SARS-COV2 variant Omicron, an expert committee on Covid immunisation is considering to recommend an ā€œadditional doseā€ to those who are immunocompromised or are..
IndiaTimes - Published

In view of new Covid variant, govt lists measures to be followed by states/UTs

In view of the possible threat that Omicron - the SARS-CoV2 variant of concern - can pose to the country, the Centre advised states and UTs to immediately focus on intensive containment, active..
IndiaTimes - Published

Covaxin well tolerated, phase 3 data shows 77.8% efficacy against symptomatic Covid: Lancet

Just a week after the World Health Organisation (WHO) granted Emergency Use Listing (EUL) to Covaxin, prestigious medical journal Lancet has stated that phase 3 data of the vaccine demonstrates 77.8%..
IndiaTimes - Published

Covid-19: Policy on booster shot soon, says panel member

Dr NK Arora, co-chair of INSACOG, a 28-lab consortium set up to monitor genomic variations in SARS-CoV-2, urged people not to take a booster dose right now as it wonā€™t be considered for any..
IndiaTimes - Published

Covid has entered endemic phase in India, says expert

The chances of a third Covid-19 wave appear remote under the ā€œpresent circumstancesā€ with only the Delta and its derivatives as the main SARS-CoV-2 variants in circulation and the weekly caseload..
IndiaTimes - Published

Stuck in India for up to a year, 11 Filipino kids and kin return home

Dr Neerav Goyal, senior liver transplant surgeon at Apollo, said it was heartening to find that though they were on immunosuppressive therapy, the four kids infected by Covid did well. ā€œIt reinforces..
IndiaTimes - Published

Covid-19: Breakthrough infection common due to Delta, report says

Breakthrough infections of SARS-CoV2 after vaccination against Covid-19 are common across the globe during Delta outbreaks and genome sequencing of such cases in India currently also shows high..
IndiaTimes - Published

Easing of lockdown, non-adherence to Covid norms behind surge in infections: Govt

Easing of lockdown combined with pandemic fatigue, lack of community adherence to Covid-appropriate behavior, and circulation of more transmissible variants of SARS-CoV-2 can be attributed to the surge..
IndiaTimes - Published

COVID vaccine booster shot might be needed as new variants are emerging: AIIMS chief

As various mutations of the SARS-CoV-2 are emerging, AIIMS chief Dr Randeep Guleria said there might be a need for India to adopt a booster dose
DNA - Published

68% of Indians have Covid-19 antibodies, 1/3rd vulnerable

At least one-third of Indians are still vulnerable to Covid-19 infection, health officials have said, while sharing the findings of the fourth national sero survey, which shows 67.6% of the general..
IndiaTimes - Published

Covid-19: Variants of Concern found in 174 districts

Variants of Concern of SARS-CoV2 have been found in 174 districts in the country with the highest numbers in Maharashtra, Delhi, Punjab, Telangana, West Bengal and Gujarat, the Union health ministry..
IndiaTimes - Published

Ayush Ministry refutes claims of liver damage linked to Giloy - read what all it said

Giloy is among the several alternative medicines recommended by the Ayush Ministry as an immune booster against the COVID-19 causing SARS-CoV-2.
DNA - Published

Lambda variant: What is the new strain of COVID-19, which is deadlier than Delta, detected in the UK

"Virus evolution continues to be expected, and the more SARS-CoV-2 circulates, the more opportunities it has to evolve," WHO said.
DNA - Published

Covid-19: ā€˜No. of cases, exposure duration affect spreadā€™

The coronavirus is also an airborne infection but the chance of picking up SARS-CoV-2 in the air is directly related to the number of Covid-19 positive cases in a room, their symptomatic status, and..
IndiaTimes - Published

Covaxin effectively neutralises Delta and Alpha variants: Top US body

In yet another booster shot of endorsement for Indiaā€™s first indigenously developed Covid-19 vaccine Covaxin, the United Statesā€™ National Institutes of Health has said that the vaccine is able to..
IndiaTimes - Published

Current Covid vaccines may be less effective against Beta variant: Study

A study of the spike protein of SARS-CoV-2, the virus which causes Covid-19, suggests that current vaccines may be less effective against the Beta variant first identified in South Africa...
IndiaTimes - Published

Covishield, Covaxin work against SARS-CoV-2's Alpha, Beta, Gamma, Delta variants: Government

Vaccines Covishield and Covaxin work against SARS-CoV-2 variants Alpha, Beta, Gamma and Delta, while effectiveness tests against the Delta Plus variant is ongoing, the government said on Friday.
IndiaTimes - Published

Study reveals COVID-19 could activate TB and other dormant bacterial infections

Many viruses, including SARS-CoV-2, cause a temporary immunosuppressive effect, which causes dormant bacterial infections to come back to life.
DNA - Published

Desi expert traces ā€˜great grandpaā€™ of SARS-CoV-2


IndiaTimes - Published

1 dead as 9 out of 11 lions test positive for SARS-CoV-2 at Chennai Zoo

All the lions which have tested positive are under close observation and on prescribed treatment regimen, said the authorities.
DNA - Published

IISc study shows forms of SARS-CoV2 S-protein

A research team from the Indian Institute of Science (IISc) has made a crucial breakthrough by successfully visualising different conformations or forms of the S-protein of the SARS-CoV2 ā€” the virus..
IndiaTimes - Published

How are facemasks effective in limiting COVID-19 spread? Know here

"Masks will remain an important protective measure against SARS-Cov-2 infection -- even for vaccinated persons," head of a Berlin University said.
DNA - Published

Aerosols carrying Covid-19 virus can travel in air up to 10 meters: Centre

Cautioning people to maintain social distance to prevent the transmission of the Covid-19 virus, the office of the Principal Scientific Adviser to the Government of India on Thursday said that..
IndiaTimes - Published

B.1.617 variant of SARS-CoV2 has sub-lineages; B.1.617.2 more infectious: Expert


IndiaTimes - Published

60% of Indian variant samples tested in labs found in Maharshtra

About 59% samples of the newly identified and infectious Indian variant of SARS-CoV-2 called B.1.617 have been found in Maharashtra, although the double mutant strain is dominant only in selected..
IndiaTimes - Published

Covaxin neutralises double mutant strain, effective against multiple variants of SARS-CoV-2: ICMR

Bharat Biotech's Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries across the globe.
DNA - Published